# Vertex RAG API run — 2026-02-11T13:22:49
## Context
- Project: `project-c586e8b1-1e15-4a02-a16`
- Location: `europe-west4`
- Corpus: `projects/387720717318/locations/europe-west4/ragCorpora/6917529027641081856`
- Model: `gemini-2.0-flash-001`
- Retrieval: `top_k=8`
- Filter: `vector_distance_threshold=0.6`
- Request: `900df0540c89`
- Latency: `2940ms`
- Retrieved: `chunks=8`, `docs=8`
- Guardrails: `top_k_max=10`, `max_output_tokens=512`

## Links
- report: `/runs/2026-02-11/900df0540c89/report`
- demo: `/runs/2026-02-11/900df0540c89/demo`
- grounding: `/runs/2026-02-11/900df0540c89/grounding`
- citations: `/runs/2026-02-11/900df0540c89/citations`

## Prompt
```text
What is the proportion of incidents by type of medication?
```

## Answer
The most reported drugs were amoxicillin/clavulanic acid (12.1%), ibuprofen (9.6%), ketoprofen (8.9%), diclofenac (6.4%), paracetamol (4.3%), clarithromycin (3.9%), and ceftriaxone and amoxicillin (3%). For serious ADR reports within each therapeutic group, antibacterial drugs included the largest within-class proportion of serious cases (43%), followed by anti-inflammatory drugs (41.5%), anesthetics (34.6%), and analgesics (32.4%).

## Sources (with excerpts)

### 1. pmc_12842238.txt
- PMC: `https://pmc.ncbi.nlm.nih.gov/articles/PMC12842238/`
- ID: `pmc_12842238`

> The most reported drugs, calculated on the total of all reports, were amoxicillin/clavulanic acid (12.1%), ibuprofen (9.6%), ketoprofen (8.9%), diclofenac (6.4%), paracetamol (4.3%), clarithromycin (3.9%), and ceftriaxone and amoxicillin (3%). Considering serious ADR reports with…

### 2. pmc_12825815.txt
- PMC: `https://pmc.ncbi.nlm.nih.gov/articles/PMC12825815/`
- ID: `pmc_12825815`

> Each report may involve multiple drugs and adverse events, which are coded using preferred terms (PTs) from the Medical Dictionary for Regulatory Activities (MedDRA). MedDRA employs a five-level hierarchical classification system: from the broadest system organ class (SOC) down t…

### 3. pmc_12825815.txt
- PMC: `https://pmc.ncbi.nlm.nih.gov/articles/PMC12825815/`
- ID: `pmc_12825815`

> These reports are submitted by healthcare providers, consumers, and pharmaceutical companies. T
> 
> e of the largest pharmacovigilance databases globally. These reports are submitted by healthcare providers, consumers, and pharmaceutical companies. The latter are obligated to report…

### 4. pmc_12858017.txt
- PMC: `https://pmc.ncbi.nlm.nih.gov/articles/PMC12858017/`
- ID: `pmc_12858017`

> Injury, poisoning, and procedural complications. Investigations. Product issues. Social circumstances. Surgical and medical procedures. This aligns with methodologies used in prior studies, excluding non-pharmacological SOC categories and focussing on ADRs potentially associated …

### 5. pmc_12845191.txt
- PMC: `https://pmc.ncbi.nlm.nih.gov/articles/PMC12845191/`
- ID: `pmc_12845191`

> Duplicates and invalid SRs were excluded. The validation procedure was carried out in accordance with paragraph 407 of the “Rules of Good Pharmacovigilance Practice of the EAEU” [ 69 ], according to which SRs must contain four essential elements: an identifiable reporter, an iden…

### 6. pmc_12859359.txt
- PMC: `https://pmc.ncbi.nlm.nih.gov/articles/PMC12859359/`
- ID: `pmc_12859359`

> However, its retrospective designs, possible underreporting of mild instances and dependence on clinical judgment instead of challenge testing or biopsy for causality proof are some of its drawbacks. All things considered, this study reaffirms the clinical relevance of drug-induc…

### 7. pmc_12858017.txt
- PMC: `https://pmc.ncbi.nlm.nih.gov/articles/PMC12858017/`
- ID: `pmc_12858017`

> Injury, poisoning, and procedural complications. Investigations. Product issues. Social circumstances. Surgical and medical procedures. This aligns with methodologies used in prior studies, excluding non-pharmacological SOC categories and focussing on ADRs potentially associated …

### 8. pmc_12845191.txt
- PMC: `https://pmc.ncbi.nlm.nih.gov/articles/PMC12845191/`
- ID: `pmc_12845191`

> PRR and ROR values, along with their corresponding 95% confidence intervals (CIs), were calculated for each of the top 10 drugs with the highest reporting proportions at the SMQ SCAR level. Disproportionality analysis performed with PRR calculation revealed notable sa
> 
> 10 drugs w…

